Senti Bio to Host Investor Event Highlighting SENTI-202 at

– Review of new preclinical data and clinical development plan for SENTI-202 in hematologic malignancies; also featuring KOL discussion of treatment...

Related Keywords

United States ,American ,Stephena Strickland Jr , ,Leukemia Research ,Linkedin ,Twitter ,Senti Biosciences Inc ,Nasdaq ,American Society Of Hematology ,Exchange Commission ,Securities Exchange ,Investor Event ,American Society ,Annual Meeting ,New Orleans ,Sarah Cannon Transplant ,Cellular Therapy Network ,Gene Circuits ,Gene Circuit ,Spark Therapeutics ,Bluerock Therapeutics ,Securities Act ,Securities Exchange Act ,Senti Bio ,Senti Biosciences ,Nasdaq Snti ,Nc ,Pml ,Yntheticbiology ,Ogicgating ,Enecircuits ,